Back to Journals » Neurobehavioral HIV Medicine » Volume 4

The neuro-ophthalmology of HIV-AIDS review of Neurobehavioral HIV Medicine

Authors Sudhakar, Kedar S, Berger

Received 9 March 2012

Accepted for publication 23 May 2012

Published 18 September 2012 Volume 2012:4 Pages 99—111

DOI https://doi.org/10.2147/NBHIV.S24204

Review by Single-blind

Peer reviewer comments 4

Padmaja Sudhakar,1 Sachin Kedar,1,2 Joseph R Berger1,3

1
Departments of Neurology, University of Kentucky College of Medicine, Lexington, KY, USA; 2Departments of Ophthalmology, University of Kentucky College of Medicine, Lexington, KY, USA; 3Departments of Internal Medicine, University of Kentucky College of Medicine, Lexington, KY, USA

Abstract: Neuro-ophthalmic problems are known to occur both in human immunodeficiency virus (HIV) infection and AIDS. Central nervous system (CNS) opportunistic infections and malignancies such as lymphoma are the major source of these problems but some result from the direct effect of the virus on the CNS. Both the afferent visual pathway and efferent ocular motor system may be affected. Neuro-ophthalmic signs may sometimes be the initial manifestation of AIDS. A variety of neuro-ophthalmic manifestations may be encountered in the same patient. Several large studies on the ophthalmic features of AIDS have included neuro-ophthalmic manifestations in their series. However dedicated comprehensive review articles on this subject are few. Despite the introduction of highly active antiretroviral therapy (HAART), neuro-ophthalmic manifestations still remain a problem in HIV. The aim of this article is to provide an overview of the neuro-ophthalmic sequelae of AIDS.

Keywords: HIV, AIDS, ophthalmology, eye, pupil, cranial nerve, ocular motility, visual loss

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] 

 

Readers of this article also read:

Emerging and future therapies for hemophilia

Carr ME, Tortella BJ

Journal of Blood Medicine 2015, 6:245-255

Published Date: 3 September 2015

Cissus quadrangularis inhibits IL-1β induced inflammatory responses on chondrocytes and alleviates bone deterioration in osteotomized rats via p38 MAPK signaling

Kanwar JR, Samarasinghe RM, Kumar K, Arya R, Sharma S, Zhou SF, Sasidharan S, Kanwar RK

Drug Design, Development and Therapy 2015, 9:2927-2940

Published Date: 5 June 2015

A new recombinant factor VIII: from genetics to clinical use

Santagostino E

Drug Design, Development and Therapy 2014, 8:2507-2515

Published Date: 12 December 2014

A novel preparation method for silicone oil nanoemulsions and its application for coating hair with silicone

Hu Z, Liao M, Chen Y, Cai Y, Meng L, Liu Y, Lv N, Liu Z, Yuan W

International Journal of Nanomedicine 2012, 7:5719-5724

Published Date: 12 November 2012

Cross-linked acrylic hydrogel for the controlled delivery of hydrophobic drugs in cancer therapy

Deepa G, Thulasidasan AK, Anto RJ, Pillai JJ, Kumar GS

International Journal of Nanomedicine 2012, 7:4077-4088

Published Date: 27 July 2012

Topical diclofenac in the treatment of osteoarthritis of the knee

Niklas Schuelert, Fiona A Russell, Jason J McDougall

Orthopedic Research and Reviews 2011, 3:1-8

Published Date: 6 February 2011